Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | MET proto-oncogene, receptor tyrosine kinase | Starlite/ChEMBL | References |
Homo sapiens | kinase insert domain receptor | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Loa Loa (eye worm) | TK/KIN16 protein kinase | Get druggable targets OG5_130320 | All targets in OG5_130320 |
Onchocerca volvulus | Tyrosine kinase homolog | Get druggable targets OG5_130320 | All targets in OG5_130320 |
Onchocerca volvulus | Get druggable targets OG5_130320 | All targets in OG5_130320 | |
Brugia malayi | Immunoglobulin I-set domain containing protein | Get druggable targets OG5_130320 | All targets in OG5_130320 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | hypothetical protein | 0.0012 | 0.0078 | 0.0078 |
Loa Loa (eye worm) | hypothetical protein | 0.0011 | 0.0058 | 0.0058 |
Loa Loa (eye worm) | plexin A | 0.0025 | 0.0365 | 0.0365 |
Echinococcus granulosus | neurotracting:lsamp:neurotrimin:obcam | 0.0015 | 0.0141 | 0.0141 |
Schistosoma mansoni | cell adhesion molecule | 0.0015 | 0.0141 | 0.0141 |
Echinococcus granulosus | defective proboscis extension response | 0.0011 | 0.0058 | 0.0058 |
Brugia malayi | plexin A | 0.0025 | 0.0365 | 0.0365 |
Echinococcus multilocularis | serotonin receptor | 0.025 | 0.5513 | 0.5513 |
Schistosoma mansoni | nephrin | 0.0014 | 0.0123 | 0.0123 |
Loa Loa (eye worm) | hypothetical protein | 0.025 | 0.5513 | 0.5513 |
Echinococcus granulosus | Immunoglobulin | 0.0011 | 0.0058 | 0.0058 |
Brugia malayi | Fibronectin type III domain containing protein | 0.0011 | 0.0058 | 0.0058 |
Schistosoma mansoni | defective proboscis extension response (dpr)-related | 0.0011 | 0.0058 | 0.0058 |
Echinococcus multilocularis | basement membrane specific heparan sulfate | 0.0011 | 0.0058 | 0.0058 |
Echinococcus multilocularis | plexin a4 | 0.0025 | 0.0365 | 0.0365 |
Loa Loa (eye worm) | hypothetical protein | 0.0011 | 0.0058 | 0.0058 |
Loa Loa (eye worm) | hypothetical protein | 0.0015 | 0.0141 | 0.0141 |
Loa Loa (eye worm) | hypothetical protein | 0.0011 | 0.0058 | 0.0058 |
Loa Loa (eye worm) | hypothetical protein | 0.0011 | 0.0058 | 0.0058 |
Schistosoma mansoni | biogenic amine (5HT) receptor | 0.025 | 0.5513 | 0.5513 |
Schistosoma mansoni | vesicular acetylcholine transporter | 0.0447 | 1 | 1 |
Loa Loa (eye worm) | vesicular acetylcholine transporter unc-17 | 0.0447 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0011 | 0.0058 | 0.0058 |
Loa Loa (eye worm) | hypothetical protein | 0.0375 | 0.8372 | 0.8372 |
Echinococcus multilocularis | Immunoglobulin | 0.0011 | 0.0058 | 0.0058 |
Loa Loa (eye worm) | hypothetical protein | 0.0021 | 0.0277 | 0.0277 |
Schistosoma mansoni | Neurotrimin precursor (hNT) | 0.0011 | 0.0058 | 0.0058 |
Trypanosoma cruzi | C-8 sterol isomerase, putative | 0.0375 | 0.8372 | 0.5 |
Echinococcus multilocularis | roundabout 2 | 0.0018 | 0.0207 | 0.0207 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.0207 | 0.0207 |
Onchocerca volvulus | 0.0021 | 0.0277 | 0.0277 | |
Brugia malayi | ERG2 and Sigma1 receptor like protein | 0.0375 | 0.8372 | 0.8372 |
Echinococcus multilocularis | Immunoglobulin | 0.0011 | 0.0058 | 0.0058 |
Loa Loa (eye worm) | hypothetical protein | 0.0012 | 0.0078 | 0.0078 |
Echinococcus multilocularis | serotonin receptor | 0.025 | 0.5513 | 0.5513 |
Echinococcus granulosus | biogenic amine 5HT receptor | 0.025 | 0.5513 | 0.5513 |
Echinococcus multilocularis | neuroglian | 0.0014 | 0.0123 | 0.0123 |
Echinococcus granulosus | plexin a4 | 0.0025 | 0.0365 | 0.0365 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0011 | 0.0058 | 0.0058 |
Onchocerca volvulus | Vesicular acetylcholine transporter homolog | 0.0447 | 1 | 1 |
Loa Loa (eye worm) | TK/KIN16 protein kinase | 0.0184 | 0.3994 | 0.3994 |
Loa Loa (eye worm) | hypothetical protein | 0.0192 | 0.4181 | 0.4181 |
Loa Loa (eye worm) | hypothetical protein | 0.025 | 0.5513 | 0.5513 |
Schistosoma mansoni | plexin | 0.0021 | 0.0277 | 0.0277 |
Brugia malayi | hypothetical protein | 0.0011 | 0.0058 | 0.0058 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.0207 | 0.0207 |
Leishmania major | C-8 sterol isomerase-like protein | 0.0375 | 0.8372 | 0.5 |
Schistosoma mansoni | vesicular amine transporter | 0.0012 | 0.0067 | 0.0067 |
Schistosoma mansoni | plexin | 0.0012 | 0.0078 | 0.0078 |
Echinococcus granulosus | roundabout 2 | 0.0018 | 0.0207 | 0.0207 |
Trypanosoma brucei | C-8 sterol isomerase, putative | 0.0375 | 0.8372 | 0.5 |
Onchocerca volvulus | 0.0167 | 0.3607 | 0.3607 | |
Onchocerca volvulus | Tyrosine kinase homolog | 0.0172 | 0.3719 | 0.3719 |
Echinococcus multilocularis | vesicular acetylcholine transporter | 0.0447 | 1 | 1 |
Echinococcus granulosus | twitchin | 0.0014 | 0.0123 | 0.0123 |
Brugia malayi | Plexin repeat family protein | 0.0021 | 0.0277 | 0.0277 |
Echinococcus granulosus | vesicular acetylcholine transporter | 0.0447 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0011 | 0.0058 | 0.0058 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0184 | 0.3994 | 0.3994 |
Echinococcus granulosus | neuroglian | 0.0014 | 0.0123 | 0.0123 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 116 nM | Inhibition of GST tagged c-Met (unknown origin) expressed in Sf9 cells | ChEMBL. | 18434145 |
IC50 (binding) | = 116 nM | Inhibition of GST tagged c-Met (unknown origin) expressed in Sf9 cells | ChEMBL. | 18434145 |
IC50 (binding) | = 116 nM | Inhibition of human c-MET | ChEMBL. | 21641696 |
IC50 (binding) | = 1134 nM | Inhibition of GST tagged VEGFR2 (unknown origin) expressed in Sf9 cells | ChEMBL. | 18434145 |
IC50 (binding) | = 1134 nM | Inhibition of GST tagged VEGFR2 (unknown origin) expressed in Sf9 cells | ChEMBL. | 18434145 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
2 literature references were collected for this gene.